Literature DB >> 17230618

Short-term application of low-dose growth hormone in surgical patients: effects on nitrogen balance and blood glucose.

Ming-Ming Zhang1, Xiao-Ting Wu, Yong Zhou, Kun Qian, Ya-Min Zheng.   

Abstract

AIM: To investigate the effectiveness and safety of recombinant human growth hormone (rhGH) in postoperative patients.
METHODS: A total of 48 consecutive patients undergoing abdominal operations were randomized to receive either subcutaneous rhGH (0.15 IU/kg) or placebo (menstruum) injections daily for 7 d after surgery. The two groups had similar nutritional intake. Blood samples for serum fibronectin, albumin, prealbumin, transferrin and the total lymphocyte count, as well as glucose levels were collected to study the rhGH effect. Basal laboratory evaluation, and nutritional status were estimated on d 1 before as baseline and d 3 and 10 after operation using standard laboratory techniques. Nitrogen balance was measured from d 3 to 9 after operation.
RESULTS: The cumulative nitrogen balance was significantly improved in rhGH group compared with the placebo group (11.37 +/- 16.82 vs -9.11 +/- 17.52, P = 0.0003). Serum fibronectin was also significantly higher in the rhGH group than in the placebo group (104.77 +/- 19.94 vs 93.03 +/- 16.03, P < 0.05), whereas changes in serum albumin, prealbumin, transferrin and total lymphocyte counts were not statistically significant. Mean blood glucose levels were significantly higher in the rhGH group from d 3 to 6 after operation.
CONCLUSION: If blood glucose can be controlled, low-dose growth hormone together with hypocaloric nutrition is effective on improving positive nitrogen balance and protein conservation and safe is in postoperative patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17230618      PMCID: PMC4065904          DOI: 10.3748/wjg.v13.i3.452

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  Increased mortality associated with growth hormone treatment in critically ill adults.

Authors:  J Takala; E Ruokonen; N R Webster; M S Nielsen; D F Zandstra; G Vundelinckx; C J Hinds
Journal:  N Engl J Med       Date:  1999-09-09       Impact factor: 91.245

2.  Intensive insulin therapy in critically ill patients.

Authors:  G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

3.  Continuation of growth hormone (GH) substitution during fasting in GH-deficient patients decreases urea excretion and conserves protein synthesis.

Authors:  H Nørrelund; N Møller; K S Nair; J S Christiansen; J O Jørgensen
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

4.  Combination of recombinant human growth hormone and glutamine-enriched total parenteral nutrition to surgical patients: effects on circulating amino acids.

Authors:  O Kolstad; T G Jenssen; O C Ingebretsen; E Vinnars; A Revhaug
Journal:  Clin Nutr       Date:  2001-12       Impact factor: 7.324

5.  Long-term risk of gastrointestinal tumor recurrence after postoperative treatment with recombinant human growth hormone.

Authors:  J Tacke; U Bolder; A Herrmann; G Berger; K W Jauch
Journal:  JPEN J Parenter Enteral Nutr       Date:  2000 May-Jun       Impact factor: 4.016

6.  The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown.

Authors:  H Nørrelund; K S Nair; J O Jørgensen; J S Christiansen; N Møller
Journal:  Diabetes       Date:  2001-01       Impact factor: 9.461

7.  Growth hormone safety update from the National Cooperative Growth Study.

Authors:  T Maneatis; J Baptista; K Connelly; S Blethen
Journal:  J Pediatr Endocrinol Metab       Date:  2000-09       Impact factor: 1.634

8.  Effects of growth hormone on adipose tissue.

Authors:  A L Carrel; D B Allen
Journal:  J Pediatr Endocrinol Metab       Date:  2000-09       Impact factor: 1.634

9.  Growth hormone together with glutamine-containing total parenteral nutrition maintains muscle glutamine levels and results in a less negative nitrogen balance after surgical trauma.

Authors:  F Hammarqvist; A Sandgren; K Andersson; P Essén; M A McNurlan; P J Garlick; J Wernerman
Journal:  Surgery       Date:  2001-05       Impact factor: 3.982

10.  A randomized controlled trial of low-dose recombinant human growth hormone in the treatment of malnourished elderly medical patients.

Authors:  L W Chu; K S Lam; S C Tam; W J Hu; S L Hui; A Chiu; K C Chiu; P Ng
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

View more
  2 in total

1.  Tendon and skeletal muscle matrix gene expression and functional responses to immobilisation and rehabilitation in young males: effect of growth hormone administration.

Authors:  A P Boesen; K Dideriksen; C Couppé; S P Magnusson; P Schjerling; M Boesen; M Kjaer; H Langberg
Journal:  J Physiol       Date:  2013-09-30       Impact factor: 5.182

2.  A Screening Tool to Detect Chronic Critically Ill Cardiac Surgery Patients at Risk for Low Levels of Testosterone and Somatomedin C: A Prospective Observational Pilot Study.

Authors:  Ceressa T Ward; David W Boorman; Ava Afshar; Amit Prabhakar; Babar Fiza; Laura R Pyronneau; Amber Kimathi; Carmen Paul; Berthold Moser; Vanessa Moll
Journal:  Cureus       Date:  2021-05-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.